Table of Contents Author Guidelines Submit a Manuscript
International Journal of Genomics
Volume 2014, Article ID 612972, 8 pages
http://dx.doi.org/10.1155/2014/612972
Review Article

Association between NFKB1 −94ins/del ATTG Promoter Polymorphism and Cancer Susceptibility: An Updated Meta-Analysis

Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

Received 21 February 2014; Accepted 13 April 2014; Published 7 May 2014

Academic Editor: Ji-Fu Wei

Copyright © 2014 Xiao Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, The GLob L Burden of Disease: 2004 Update, World Health Organization, Geneva, Switzerland, 2008.
  2. W. D. Foulkes, “Inherited susceptibility to common cancers,” The New England Journal of Medicine, vol. 359, no. 20, pp. 2143–2153, 2008. View at Google Scholar
  3. R. Sen and D. Baltimore, “Inducibility of K immunoglobulin enhancer-binding protein NF-kB by a posttranslational mechanism,” Cell, vol. 47, no. 6, pp. 921–928, 1986. View at Google Scholar · View at Scopus
  4. F. Chen, V. Castranova, X. Shi, and L. M. Demers, “New insights into the role of nuclear factor-κB, a ubiquitous transcription factor in the initiation of diseases,” Clinical Chemistry, vol. 45, no. 1, pp. 7–17, 1999. View at Google Scholar · View at Scopus
  5. X. F. Sun and H. Zhang, “NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases,” Histology and histopathology, vol. 22, no. 12, pp. 1387–1398, 2007. View at Google Scholar · View at Scopus
  6. F. Chen, V. Castranova, X. Shi, and L. M. Demers, “New insights into the role of nuclear factor-κB, a ubiquitous transcription factor in the initiation of diseases,” Clinical Chemistry, vol. 45, no. 1, pp. 7–17, 1999. View at Google Scholar · View at Scopus
  7. Y. Yu, Y. Wan, and C. Huang, “The biological functions of NF-κB1 (p50) and its potential as an anti-cancer target,” Current Cancer Drug Targets, vol. 9, no. 4, pp. 566–571, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A. S. Karban, T. Okazaki, C. I. M. Panhuysen et al., “Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis,” Human Molecular Genetics, vol. 13, no. 1, pp. 35–45, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. F. Zou, F. L. Yuan, X. L. Feng et al., “Association between NFKB1 -94ins/delATTG promoter polymorphism and cancer risk: A meta-analysis,” Cancer Investigation, vol. 29, no. 1, pp. 78–85, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Cai, L. Sun, L. Cui et al., “Functional insertion/deletion polymorphism (-94 ins/del ATTG) in the promoter region of the NFKB1 gene is related to the risk of renal Cell Carcinoma.,” Urologia Internationalis, vol. 91, no. 2, pp. 206–212, 2013. View at Google Scholar
  11. A. Lewander, A. K. R. Butchi, J. Gao et al., “Polymorphism in the promoter region of the NFKB1 gene increases the risk of sporadic colorectal cancer in Swedish but not in Chinese populations,” Scandinavian Journal of Gastroenterology, vol. 42, no. 11, pp. 1332–1338, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Li, J. Gu, X. Yang et al., “Functional promoter -94 ins/del ATTG polymorphism in NFKB1 gene is associated with bladder cancer risk in a chinese population,” PLoS ONE, vol. 8, no. 8, Article ID e71604, 2013. View at Google Scholar
  13. W. G. Cochran, “The comparison of percentages in matched samples,” Biometrika, vol. 37, no. 3-4, pp. 256–266, 1950. View at Google Scholar · View at Scopus
  14. M. Egger, G. D. Smith, M. Schneider, and C. Minder, “Bias in meta-analysis detected by a simple, graphical test,” British Medical Journal, vol. 315, no. 7109, pp. 629–634, 1997. View at Google Scholar · View at Scopus
  15. A. E. Stuck, L. Z. Rubenstein, and D. Wieland, “Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity,” British Medical Journal, vol. 316, no. 7129, pp. 469–471, 1998. View at Google Scholar · View at Scopus
  16. S. C. Lin, C. J. Liu, W. I. Yeh, M. T. Lui, K. W. Chang, and C. S. Chang, “Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers,” Cancer Letters, vol. 243, no. 1, pp. 47–54, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Riemann, L. Becker, H. Struwe, H. Rübben, A. Eisenhardt, and W. Siffert, “Insertion/deletion polymorphism in the promoter of NFKB1 as a potential molecular marker for the risk of recurrence in superficial bladder cancer,” International Journal of Clinical Pharmacology and Therapeutics, vol. 45, no. 8, pp. 423–430, 2007. View at Google Scholar · View at Scopus
  18. H. Bu, I. Rosdahl, X. F. Sun, and H. Zhang, “Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients.,” Journal of Cancer Research and Clinical Oncology, vol. 133, no. 11, pp. 859–866, 2007. View at Google Scholar
  19. S. S. Lo, J. H. Chen, C. W. Wu, and W. Y. Lui, “Functional polymorphism of NFKB1 promoter may correlate to the susceptibility of gastric cancer in aged patients,” Surgery, vol. 145, no. 3, pp. 280–285, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Zhang, Q. Wei, X. Li et al., “A functional insertion/deletion polymorphism in the promoter region of the NFKB1 gene increases susceptibility for prostate cancer,” Cancer Genetics and Cytogenetics, vol. 191, no. 2, pp. 73–77, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. F. S. Burnik and S. Yalçin, “NFKB1 -94 insertion/deletion ATTG polymorphism in gastroenteropancreatic neuroendocrine tumors,” Chemotherapy, vol. 55, no. 5, pp. 381–385, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Zhou, L. Rao, Y. Li et al., “A functional insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for nasopharyngeal carcinoma,” Cancer Letters, vol. 275, no. 1, pp. 72–76, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Tang, S. Cui, X. Deng et al., “Insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for superficial bladder cancer in Chinese,” DNA and Cell Biology, vol. 29, no. 1, pp. 9–12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Andersen, J. Christensen, K. Overvad, A. Tjønneland, and U. Vogel, “Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes,” BMC Cancer, vol. 10, article 484, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Zhou, M. Qie, Y. Wang et al., “Relationship between NFKB1 -94 insertion/deletion ATTG polymorphism and susceptibility of cervical squamous cell carcinoma risk,” Annals of Oncology, vol. 21, no. 3, Article ID mdp507, pp. 506–511, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Fan, W. Yu, P. Ye et al., “NFKB1 insertion/deletion promoter polymorphism increases the risk of advanced ovarian cancer in a Chinese population,” DNA and Cell Biology, vol. 30, no. 4, pp. 241–245, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. C. W. Lin, Y. S. Hsieh, C. H. Hsin et al., “Effects of NFKB1 and NFKBIA gene polymorphisms on susceptibility to environmental factors and the clinicopathologic development of oral cancer,” PLoS ONE, vol. 7, no. 4, Article ID e35078, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. A. J. Vangsted, K. R. Nielsen, T. W. Klausen, E. Haukaas, A. Tjønneland, and U. Vogel, “A functional polymorphism in the promoter region of the IL1B gene is associated with risk of multiple myeloma,” British Journal of Haematology, vol. 158, no. 4, pp. 515–518, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. Z. H. Huo, H. J. Zhong, Y. S. Zhu, B. Xing, and H. Tang, “Roles of functional NFKB1 and β-TrCP insertion/deletion polymorphisms in mRNA expression and epithelial ovarian cancer susceptibility,” Genetics and Molecular Research, vol. 12, no. 3, pp. 3435–3443, 2013. View at Google Scholar
  30. C. W. Cheng, J. L. Su, C. W. Lin et al., “Effects of NFKB1 and NFKBIA gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathological features,” PLoS ONE, vol. 8, no. 2, Article ID e56130, 2013. View at Google Scholar
  31. M. S. Mohd Suzairi, S. C. Tan, A. A. Ahmad Aizat et al., “The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer,” Cancer Epidemiology, vol. 37, no. 5, pp. 634–638, 2013. View at Google Scholar
  32. T. I. Kopp, S. Friis, J. Christensen, A. Tjønneland, and U. Vogel, “Polymorphisms in genes related to inflammation, NSAID use, and the risk of prostate cancer among Danish men,” Cancer Genetics, vol. 206, no. 7-8, pp. 266–78, 2013. View at Google Scholar
  33. M. Karin, “Nuclear factor-κB in cancer development and progression,” Nature, vol. 441, no. 7092, pp. 431–436, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. Q. Li and I. M. Verma, “NF-kappaB regulation in the immune system,” Nature Reviews Immunology, vol. 2, no. 10, pp. 725–734, 2002. View at Google Scholar
  35. T. Mukhopadhyay, J. A. Roth, and S. A. Maxwell, “Altered expression of the p50 subunit of the NF-κB transcription factor complex in non-small cell lung carcinoma,” Oncogene, vol. 11, no. 5, pp. 999–1003, 1995. View at Google Scholar · View at Scopus
  36. V. Bours, E. Dejardin, F. Goujon-Letawe, M. P. Merville, and V. Castronovo, “The NF-κB transcription factor and cancer: high expression of NF-κB- and IκB-related proteins in tumor cell lines,” Biochemical Pharmacology, vol. 47, no. 1, pp. 145–149, 1994. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Karsan, E. Yee, K. Kaushansky, and J. M. Harlan, “Cloning of a human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells,” Blood, vol. 87, no. 8, pp. 3089–3096, 1996. View at Google Scholar · View at Scopus
  38. S. Kumar and C. Baglioni, “Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor Type-2,” Journal of Biological Chemistry, vol. 266, no. 31, pp. 20960–20964, 1991. View at Google Scholar · View at Scopus
  39. E. C. LaCasse, S. Baird, R. G. Korneluk, and A. E. MacKenzie, “The inhibitors of apoptosis (IAPs) and their emerging role in cancer,” Oncogene, vol. 17, no. 25, pp. 3247–3259, 1998. View at Google Scholar · View at Scopus
  40. H. P. Glauert, J. C. Tharappel, S. Banerjee et al., “Inhibition of the promotion of hepatocarcinogenesis by 2,2′,4,4′,5,5′-hexachlorobiphenyl (PCB-153) by the deletion of the p50 subunit of NF-κB in mice,” Toxicology and Applied Pharmacology, vol. 232, no. 2, pp. 302–308, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. E. D. Cahir-McFarland, D. M. Davidson, S. L. Schauer, J. Duong, and E. Kieff, “NF-κB inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 11, pp. 6055–6060, 2000. View at Google Scholar · View at Scopus
  42. L. Bernal-Mizrachi, C. M. Lovly, and L. Ratner, “The role of NF-κB-1 and NF-κB-2-mediated resistance to apoptosis in lymphomas,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 24, pp. 9220–9225, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Yang, L. Cohn, D. H. Zhang, R. Homer, A. Ray, and P. Ray, “Essential role of nuclear factor κB in the induction of eosinophilia in allergic airway inflammation,” Journal of Experimental Medicine, vol. 188, no. 9, pp. 1739–1750, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Artis, C. M. Kane, J. Fiore et al., “Dendritic cell-intrinsic expression of NF-κB1 is required to promote optimal Th2 cell differentiation,” Journal of Immunology, vol. 174, no. 11, pp. 7154–7159, 2005. View at Google Scholar · View at Scopus
  45. S. Shukla, G. T. MacLennan, S. R. Marengo, M. I. Resnick, and S. Gupta, “Constitutive activation of PI3K-Akt and NF-κB during prostate cancer progression in autochthonous transgenic mouse model,” Prostate, vol. 64, no. 3, pp. 224–239, 2005. View at Publisher · View at Google Scholar · View at Scopus